{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00565097","recordId":"NCT00565097","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00565097-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00565097.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00565097.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2007-11-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2007-11-28","publishedAt":"2026-08-23","recordId":"NCT00565097","recordSha256":"cc5a9a496588dd6f861d33fe7a84ba9017c0d2a48b471723b189fb5f0dad6d15","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00565097?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2007-11-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2007-11-30","publishedAt":"2026-08-23","recordId":"NCT00565097","recordSha256":"d7ede17f0733691c7d41e76673ae13a90696a84da825c1847384f269a0fc4f38","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00565097?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2008-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2008-02-12","publishedAt":"2026-08-23","recordId":"NCT00565097","recordSha256":"75690d2e6553e25ed74eea50bab3d2330e11db267edc45e0aa5a54443adcb7d0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00565097?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2009-02-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2009-02-16","publishedAt":"2026-08-23","recordId":"NCT00565097","recordSha256":"af05903b2ba5759da654532d3cfc27fc8f8e577ba268e9ef48e6804ee719c188","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00565097?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"f2ae4ed7f3369c73a8e33a20f6551be29739d685598bad287d84d4376d95ec87"}}